Tamoxifen and the Risk of Endometrial Cancer in Japanese Women with Breast Cancer
Authors:
- 22 December 2005
- journal article
- Published by Springer Nature in Surgery Today
- Vol. 36 (1) , 41-46
Abstract
There is ongoing debate about whether tamoxifen for breast cancer is associated with a risk of endometrial cancer in Japanese women. We conducted a study to investigate this further. We conducted a retrospective hospital-based cohort study. A total of 674 consecutive patients underwent surgery for primary breast cancer between January 1989 and December 1998. By December 2003, endometrial cancers had been diagnosed in six of these patients. Based on medical records, we evaluated the potential risk factors for endometrial cancer, including age, menopausal status, obesity, parity, diabetes mellitus, hypertension, and tamoxifen. The 674 patients were divided into three groups based on the cumulative duration of tamoxifen use (A, 5 years). To examine the relationships between endometrial cancer and tamoxifen (and other factors), the hazards ratio (HR), 95% confidence interval (CI), and two-sided P value for endometrial cancer associated with each variable were calculated by the Cox regression method. Endometrial cancer was found in 1/318 (0.31%) patients in group A, 3/247 in group B, and 2/109 in group C. In a multivariate analysis no variable was significant, but tamoxifen use for longer than 5 years (group C) was closely correlated with endometrial cancer (HR = 7.92, CI = 0.69–90.89, P = 0.096). Although our data did not reach significance, they support a link between long-term tamoxifen and the development of endometrial cancer in Japanese women with breast cancer.Keywords
This publication has 15 references indexed in Scilit:
- Clear cell adenocarcinoma within a tamoxifen-related polypActa Obstetricia et Gynecologica Scandinavica, 2002
- Second cancers after adjuvant tamoxifen therapy for breast cancer in JapanAnnals of Oncology, 2000
- Endometrial Histopathology in 700 Patients Treated with Tamoxifen for Breast CancerGynecologic Oncology, 2000
- Adjuvant Tamoxifen Therapy for Early Stage Breast Cancer and Second Primary MalignanciesJNCI: Journal of the National Cancer Institute, 1995
- Pathology of endometrium treated with tamoxifen.Journal of Clinical Pathology, 1994
- Malignant Neoplasms of the Uterine Corpus in Patients Treated for Breast Carcinoma: The Effects of TamoxifenInternational Journal of Gynecological Pathology, 1994
- Endometrial Cancer in Tamoxifen-Treated Breast Cancer Patients: Findings From the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14 *JNCI: Journal of the National Cancer Institute, 1994
- Risk of endometrial cancer after tamoxifen treatment of breast cancerThe Lancet, 1994
- FIGO NewsInternational Journal of Gynecology & Obstetrics, 1989
- ADJUVANT TAMOXIFEN IN EARLY BREAST CANCER: OCCURRENCE OF NEW PRIMARY CANCERSThe Lancet, 1989